ArticleCurrent cancer drug targets2026

The COX-2 Inhibitor Celecoxib Sensitizes Nasopharyngeal Carcinoma Cells to Ferroptosis.

Dawei Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.